The Evolution of Immunotherapy Revolution in Lung Cancer: A 20-Year Perspective

Study limitation reported by the research below: “Several cited trials (e.g., HARMONi-2, SKYSCRAPER-01, DeLLphi) are from 2024–2026 and may represent very recent or preliminary data not yet fully peer-validated at time of reading.”